CTT Pharmaceutical Company Top Insiders
CTTH Stock | USD 0.05 0.0001 0.20% |
CTT Pharmaceutical employs about 15 people. The company is managed by 2 executives with a total tenure of roughly 35 years, averaging almost 17.0 years of service per executive, having 7.5 employees per reported executive. Assessment of CTT Pharmaceutical's management performance can provide insight into the firm performance.
Ryan Khouri Insider Chief Officer |
Marc Lakmaaker Insider Special Devel |
CTT |
CTT Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of (1.5357) % which means that it has lost $1.5357 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.4883) %, meaning that it created substantial loss on money invested by shareholders. CTT Pharmaceutical's management efficiency ratios could be used to measure how well CTT Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.CTT Pharmaceutical Workforce Comparison
CTT Pharmaceutical Holdings is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 139. CTT Pharmaceutical retains roughly 15.0 in number of employees claiming about 11% of equities under Health Care industry.
CTT Pharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CTT Pharmaceutical Price Series Summation is a cross summation of CTT Pharmaceutical price series and its benchmark/peer.
CTT Pharmaceutical Notable Stakeholders
A CTT Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CTT Pharmaceutical often face trade-offs trying to please all of them. CTT Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CTT Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ryan Khouri | Chief Officer | Profile | |
Marc Lakmaaker | Special Devel | Profile |
About CTT Pharmaceutical Management Performance
The success or failure of an entity such as CTT Pharmaceutical often depends on how effective the management is. CTT Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CTT management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CTT management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
CTT Pharmaceutical Workforce Analysis
Traditionally, organizations such as CTT Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CTT Pharmaceutical within its industry.CTT Pharmaceutical Manpower Efficiency
Return on CTT Pharmaceutical Manpower
Revenue Per Employee | 2.7K | |
Revenue Per Executive | 20K | |
Net Loss Per Employee | 92K | |
Net Loss Per Executive | 690.3K |
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |